KATHRYN E FALBERG Insider Trading $MDVN MEDIVATION, INC.
Get free email notifications about insider trading for KATHRYN E FALBERG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KATHRYN E FALBERG. KATHRYN E FALBERG is Director in HUMAN GENOME SCIENCES INC ($HGSI) and Director in MEDIVATION, INC. ($MDVN) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in HALOZYME THERAPEUTICS INC ($GYHT) and Director in aTYR PHARMA INC ($LIFE) and in Tricida, Inc. ($TCDA) and Director in Tricida, Inc. ($TCDA) and Director in Aimmune Therapeutics, Inc. ($AIMT) and Director in Axovant Sciences Ltd. ($AXON) and Director in Trade Desk, Inc. ($TTD) and Director in UroGen Pharma Ltd. ($URGN) and Director in Arcus Biosciences, Inc. ($RCUS) and Director in Nuvation Bio Inc. ($PANA).
KATHRYN E FALBERG in MEDIVATION, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KATHRYN E FALBERG: Director
Holdings: 0 shares
Latest Transaction: Sep 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KATHRYN E FALBERG in MEDIVATION, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AIMT, RCUS, LIFE, BMRN, GYHT, HGSI, MDVN, NUVB, AXON, TTD, TCDA, URGN
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Option Exercise | D | 58.89 | 6,228 | 366,767 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Option Exercise | D | 55.45 | 6,284 | 348,448 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Option Exercise | D | 38.89 | 9,584 | 372,686 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Option Exercise | D | 24.60 | 12,232 | 300,907 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Option Exercise | D | 27.18 | 30,000 | 815,400 | 0 | |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Sell | U | 0.00 | 50,000 | 0 | 0 | 50 K to 0 (-100.00 %) |
| Sep 30 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Sell | U | 0.00 | 32,742 | 0 | 0 | 32.7 K to 0 (-100.00 %) |
| Jun 23 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Option Exercise | A | 58.89 | 6,228 | 366,767 | 6,228 | |
| Jun 23 2016 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 2,972 | 0 | 32,742 | 29.8 K to 32.7 K (+9.98 %) |
| Jun 18 2015 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Option Exercise | A | 110.90 | 3,142 | 348,448 | 3,142 | |
| Jun 18 2015 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Grant | A | 0.00 | 1,578 | 0 | 14,885 | 13.3 K to 14.9 K (+11.86 %) |
| Mar 02 2015 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Buy | P | 119.11 | 800 | 95,288 | 25,000 | 24.2 K to 25 K (+3.31 %) |
| Mar 02 2015 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Buy | P | 118.37 | 1,400 | 165,718 | 24,200 | 22.8 K to 24.2 K (+6.14 %) |
| Mar 02 2015 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Buy | P | 117.76 | 19,400 | 2,284,544 | 22,800 | 3.4 K to 22.8 K (+570.59 %) |
| Mar 02 2015 | MDVN | MEDIVATION, INC. | FALBERG KATHRYN E | Director | Buy | P | 116.51 | 3,400 | 396,134 | 3,400 | 0 to 3.4 K |
Page: 1